Australia markets open in 3 hours 55 minutes

BCAL Diagnostics Limited (BDX.XA)

Cboe AU - Cboe AU Real-time price. Currency in AUD
Add to watchlist
0.1150+0.0050 (+4.55%)
At close: 01:31PM AEST
Full screen
Previous close0.1100
Bid0.1000 x N/A
Ask0.1150 x N/A
Day's range0.1050 - 0.1150
52-week range0.0700 - 0.1750
Avg. volume99,031
Market capN/A
Beta (5Y monthly)0.31
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    BCAL Findings Presented at 2023 ASCO Annual Meeting

    BCAL Diagnostics Limited (ASX:BDX) (BCAL or Company) today announced the presentation of data demonstrating the potential for detection of early breast cancer using a plasma lipidomic biomarker signature. BCAL is developing a non-invasive blood screening test that is intended to be used alongside breast cancer screening methods, such as mammography. The poster, "Lipidomic Signature From Plasma to Detect Localised Breast Cancer," was presented at the 2023 ASCO Annual Meeting (Chicago, 2-6 June 20